packageEflornithine

eflornithine

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Eflornithine is used to treat excessive facial hair growth in women (hirsutism) and, in combination therapy, the childhood cancer neuroblastoma; it has also been used against sleeping sickness. It remains authorised in the European Union for these uses, with a topical dermatological product for hirsutism and an oncology product for neuroblastoma, though some applications have been withdrawn.

Summary written by glm-5.3-flash from Wikidata Q72470623 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:eflornithine
ATC codes:D11AX16, L01XX79, P01CX03
DrugBank:DB06243
PubChem CID:3009
ChEBI:41948
Wikidata:Q72470623
formula:C6H12F2N2O2
molar mass:182.17 g/mol (PubChem CID 3009)
logP:-2.9 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown